Index of artpub/2025/320642/

Cortellini, Alessio
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials : results from the Pembro-real 5Y global registry
2025
https://ddd.uab.cat/record/320642
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Cortellini,_Alessio2025-11-22 15:59 20  
[ ]2=Determinants_of_5-year_survival_in_patients...2025-11-22 15:59 196  
[ ]3=20252025-11-22 15:59 5  
[ ]4=3206422025-11-22 15:59 34  
[TXT]320642.dirinfo2025-11-23 05:08 318  
[ ]320642.du2025-11-23 05:08 29  
[TXT]320642.dupdirs2025-11-23 05:08 0  
[TXT]320642.dupfiles2025-11-23 05:08 0  
[TXT]320642.errors2025-11-23 05:08 29  
[IMG]320642.gif2025-11-23 05:08 73K 
[IMG]320642.ico2025-11-23 05:08 12K 
[TXT]320642.info2025-11-23 05:08 28K 
[TXT]320642.md52025-11-23 05:08 45  
[ ]320642.pdf2025-11-23 05:08 3.6M 
[TXT]320642.sha12025-11-23 05:08 53  
[TXT]320642.sha2562025-11-23 05:08 77  
[TXT]320642.stats2025-11-23 05:08 294  
[TXT]320642.txt2025-11-23 05:08 0